Eric Mosbrooker is Chief Commercial Officer of Avidity Biosciences, Inc.. Currently has a direct ownership of 61,120 shares of RNA, which is worth approximately $1.65 Million. The most recent transaction as insider was on Jan 06, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.1K
n/a 3M change
n/a 12M change
Total Value Held $1.65 Million

Eric Mosbrooker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2025
BUY
Grant, award, or other acquisition
-
25,000 Added 29.03%
61,120 Common Stock

Also insider at

HZNP
Horizon Therapeutics Public Ltd Co Healthcare
EM

Eric Mosbrooker

Chief Commercial Officer
Dublin, L2

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Track Activities on RNA